Senator Cochran: Big pharma “yes,” American people “no?”

Our Senate was recently considering S. 1082, the FDA reauthorization bill, within which was a provision that would have allowed US citizens to buy prescription drugs from other countries – and at a much lower price, it should be noted. Senator Cochran introduced amendment # 1010, subsequently approved, that effectively killed the provision and blocks import of drugs from other countries unless Health and Human Services can certify to Congress that such imports “pose no additional risk to the public’s health and safety.” HHS predictably will have no interest in jeopardizing the profits of the big drug companies. Thus, free market access to prescription drugs has been denied the American public, a move that prevents the savings of billions of dollars in drug costs and provides “big pharma” – Pfizer, GlaskoSmithKline, Schering-Plough, Bristol-Myers Squibb, AstraZeneca, Johnson & Johnson, Novartis, Merck, Abbott Labs, etc., with another big win. Read the “News Target” report on the bill’s outcome here and here.

Perhaps Senator Cochran acted “To protect the health and safety of the public,” perhaps he had other motives. What do you think?

Published in: on May 30, 2007 at 1:20 pm  Leave a Comment  

The URI to TrackBack this entry is:

RSS feed for comments on this post.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: